EXAS - Exact Sciences Corporation -  [ ]

Ticker Details
Exact Sciences Corporation
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer.
IPO Date: January 31, 2001
Sector: Healthcare
Industry: Biotech
Market Cap: $19.22B
Activated in VL: False
Average Daily Range
Avg Daily Range: $0.76 | 2.70%
Avg Daily Range (30 D): $1.31 | 1.91%
Avg Daily Range (90 D): $0.99 | 1.75%
Institutional Daily Volume
Avg Daily Volume: 1.25M
Avg Daily Volume (30 D): 6.67M
Avg Daily Volume (90 D): 3.96M
Trade Size
Avg Trade Size (Sh.): 101
Avg Trade Size (Sh.) (30 D): 114
Avg Trade Size (Sh.) (90 D): 87
Institutional Trades
Total Institutional Trades: 20,831
Avg Institutional Trade: $3.29M
Avg Institutional Trade (30 D): $5.63M
Avg Institutional Trade (90 D): $4.69M
Avg Institutional Trade Volume: .06M
Avg Institutional Trades (Per Day): 7
Market Closing Trades
Avg Closing Trade: $10.49M
Avg Closing Trade (30 D): $25.28M
Avg Closing Trade (90 D): $19.45M
Avg Closing Volume: 180.87K
 
News
Feb 12, 2026 @ 10:00 PM
Mdxhealth to Present Fourth Quarter and Full Year ...
Source: Na
Jan 26, 2026 @ 11:20 AM
3 Reasons to Buy This Dividend King After Its Stee...
Source: Keith Speights
Jan 22, 2026 @ 2:48 PM
Abbott Labs Stock Hits 52-Week Low As Outlook Disa...
Source: Vandana Singh
Jan 21, 2026 @ 9:52 PM
Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC ...
Source: Halper Sadeh Llc
Jan 17, 2026 @ 5:56 PM
Halper Sadeh LLC Encourages SEE, EXAS, ZEUS Shareh...
Source: Halper Sadeh Llc
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-1.1 $-.45 $-1.1
Diluted EPS $-1.1 $-.45 $-1.1
Revenue $3.25B $878.38M $3.25B
Gross Profit $2.26B $615.83M $2.26B
Net Income / Loss $-207.95M $-85.96M $-207.95M
Operating Income / Loss $-206.3M $-82.6M $-206.3M
Cost of Revenue $984.24M $262.56M $984.24M
Net Cash Flow $349.36M $166.96M $349.36M
PE Ratio